What is Celanese Corporation's earnings per share (EPS)?

Celanese Corporation (CE) reported diluted earnings per share of -$10.64 for fiscal year 2025. This represents a 24.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Celanese Corporation (CE) Financials

Trailing 12 months to June 30, 2026

Revenue $9.7B -2.2% YoY

Net Income -$1.2B +28.9% YoY

EPS (Diluted) -$10.69 +28.3% YoY

Free Cash Flow $708.0M +12.0% YoY

Market Cap $4.8B as of Oct 7, 2026

Price / Sales 0.5x on $9.7B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 1.2x on $4.2B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 7, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CE SEC filings page.

Celanese Corporation (CE) reported $9.7B in revenue over the twelve months to Jun 30, 2026, down 2.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CE FY2025 2026-10-04

Celanese’s recent numbers show a cash-generating operation whose profits have been overwhelmed by shrinking margins and heavier leverage.

Cash conversion currently looks better than accounting earnings: FY2025 paired a net loss of $1.17B with operating cash flow of $1.15B, indicating that reported earnings were depressed by charges that did not consume equivalent current-period cash. Free cash flow rose from $531M in FY2024 to $803M in FY2025 as capital spending fell, showing that stronger cash output partly came from lighter reinvestment rather than profit recovery.

Revenue fell from $10.3B in FY2024 to $9.5B in FY2025 while gross margin compressed, indicating weaker economics per dollar sold rather than a volume issue alone. Operating losses persisted at $786M, so lower gross profit did not translate into operating stability.

Debt-to-equity rose from 1.7x in FY2023 to 2.8x in FY2025, making the capital structure more debt-heavy. Total liabilities were $17.6B in FY2025, close to FY2024, while equity fell to $4.0B; leverage therefore increased chiefly through a thinner equity base.

Financial Health Signals

Financial Health Score 32/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Celanese Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Celanese Corporation has an operating margin of -8.2%, meaning the company loses $8 on every $100 of revenue. This results in a profitability score of 24/100. This is down from -7.0% the prior year.

Growth

Celanese Corporation's revenue declined 7.1% year-over-year, from $10.3B to $9.5B. This contraction results in a growth score of 13/100.

Leverage

Celanese Corporation has elevated debt relative to equity (D/E of 2.81), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 23/100, reflecting increased financial risk.

Liquidity

Celanese Corporation's current ratio of 1.55 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Celanese Corporation has a free cash flow margin of 8.4%, earning a moderate score of 60/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Celanese Corporation posts a -28.8% return on equity (ROE), meaning it loses $29 for every $100 of shareholders' equity. This results in a returns score of 26/100. This is up from -30.1% the prior year.

Altman Z-Score Distress

1.23

Celanese Corporation scores 1.23, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

4/9

Celanese Corporation passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

Celanese Corporation reported a net loss of $1.2B while generating $1.1B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Celanese Corporation reported an operating loss of $786.0M against $701.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.8B

YoY+8.7%

QoQ+17.8%

5Y CAGR+4.6%

10Y CAGR+7.4%

Celanese Corporation generated $2.8B in revenue in Q2 2026. This represents an increase of 8.7% from the same quarter a year earlier. Against the prior quarter it is up 17.8%.

EBITDA

$520.0M

YoY+23.5%

QoQ+25.3%

5Y CAGR-4.6%

10Y CAGR+5.1%

Celanese Corporation's EBITDA was $520.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 23.5% from the same quarter a year earlier. Against the prior quarter it is up 25.3%.

Net Income

$125.0M

YoY-36.5%

QoQ+184.1%

5Y CAGR-25.3%

10Y CAGR-5.5%

Celanese Corporation reported $125.0M in net income in Q2 2026. This represents a decrease of 36.5% from the same quarter a year earlier. Against the prior quarter it is up 184.1%.

EPS (Diluted)

$1.13

YoY-37.2%

QoQ+182.5%

5Y CAGR-25.0%

10Y CAGR-2.8%

Celanese Corporation earned $1.13 per diluted share (EPS) in Q2 2026. This represents a decrease of 37.2% from the same quarter a year earlier. Against the prior quarter it is up 182.5%.

Cash & Balance Sheet

Free Cash Flow

$147.0M

YoY-53.6%

QoQ+1370.0%

5Y CAGR-14.2%

10Y CAGR-6.6%

Celanese Corporation generated $147.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 53.6% from the same quarter a year earlier. Against the prior quarter it is up 1370.0%.

Cash & Debt

$1.4B

YoY+16.3%

QoQ-22.4%

5Y CAGR+5.3%

10Y CAGR+6.4%

Celanese Corporation held $1.4B in cash against $10.7B in long-term debt as of Q2 2026.

Shares Outstanding

110M

YoY+0.2%

QoQ+0.1%

5Y CAGR-0.2%

10Y CAGR-2.7%

Celanese Corporation had 110M shares outstanding in Q2 2026. This represents an increase of 0.2% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

22.5%

YoY+1.4pp

QoQ+2.4pp

5Y change-12.2pp

10Y change-2.6pp

Celanese Corporation's gross margin was 22.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.

Operating Margin

10.0%

YoY+0.9pp

QoQ+0.9pp

5Y change-15.8pp

10Y change-8.0pp

Celanese Corporation's operating margin was 10.0% in Q2 2026, reflecting core business profitability. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Net Margin

4.5%

YoY-3.2pp

QoQ+2.7pp

5Y change-19.9pp

10Y change-11.8pp

Celanese Corporation's net profit margin was 4.5% in Q2 2026, showing the share of revenue converted to profit. This is down 3.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.7 percentage points.

Return on Equity

3.0%

YoY-0.8pp

QoQ+1.9pp

5Y change-11.2pp

10Y change-5.5pp

Celanese Corporation's ROE was 3.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.

Capital Allocation

R&D Spending

$29.0M

YoY-6.5%

QoQ+3.6%

5Y CAGR+5.7%

10Y CAGR+4.3%

Celanese Corporation invested $29.0M in research and development in Q2 2026. This represents a decrease of 6.5% from the same quarter a year earlier. Against the prior quarter it is up 3.6%.

Capital Expenditures

$62.0M

YoY-33.3%

QoQ-6.1%

5Y CAGR-10.8%

10Y CAGR+0.7%

Celanese Corporation invested $62.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 33.3% from the same quarter a year earlier. Against the prior quarter it is down 6.1%.

Share Buybacks

Not reported for Q2 2026.

CE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CE quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$9.7B	$9.5B-7.1%	$10.3B-6.0%	$10.9B+13.0%	$9.7B+13.3%	$8.5B+51.0%	$5.7B-10.2%	$6.3B-12.0%	$7.2B+16.5%	$6.1B+13.9%	$5.4B-5.0%	$5.7B-16.6%	$6.8B+4.5%	$6.5B+1.4%	$6.4B-5.1%	$6.8B
Cost of Revenue	$7.7B	$7.6B-4.3%	$7.9B-4.9%	$8.3B+14.4%	$7.3B+24.6%	$5.9B+34.2%	$4.4B-7.0%	$4.7B-9.5%	$5.2B+12.0%	$4.6B+16.2%	$4.0B-8.5%	$4.4B-16.0%	$5.2B+0.8%	$5.1B-1.8%	$5.2B-1.7%	$5.3B
Gross Profit	$2.0B	$2.0B-16.4%	$2.3B-9.6%	$2.6B+8.5%	$2.4B-11.3%	$2.7B+107.4%	$1.3B-19.5%	$1.6B-18.6%	$2.0B+30.5%	$1.5B+7.5%	$1.4B+6.6%	$1.3B-18.4%	$1.6B+18.4%	$1.4B+15.6%	$1.2B-17.6%	$1.4B
R&D Expenses	$120.0M	$125.0M-3.8%	$130.0M-11.0%	$146.0M+30.4%	$112.0M+30.2%	$86.0M+16.2%	$74.0M+10.4%	$67.0M-6.9%	$72.0M-1.4%	$73.0M-6.4%	$78.0M-34.5%	$119.0M+38.4%	$86.0M+1.2%	$85.0M-18.3%	$104.0M+8.3%	$96.0M
SG&A Expenses	$931.0M	$899.0M-13.0%	$1.0B-4.1%	$1.1B+30.7%	$824.0M+30.2%	$633.0M+31.3%	$482.0M-0.2%	$483.0M-11.5%	$546.0M+10.1%	$496.0M+31.2%	$378.0M-25.3%	$506.0M-33.2%	$758.0M+143.7%	$311.0M-62.5%	$830.0M+54.9%	$536.0M
Operating Income	-$692.0M	-$786.0M-9.2%	-$720.0M-143.2%	$1.7B+20.8%	$1.4B-29.2%	$1.9B+193.1%	$664.0M-20.4%	$834.0M-37.5%	$1.3B+55.7%	$857.0M-8.2%	$934.0M+186.5%	$326.0M-57.0%	$758.0M-49.7%	$1.5B+761.7%	$175.0M-74.6%	$690.0M
EBITDA	N/A	-$26.0M-132.1%	$81.0M-96.6%	$2.4B+28.9%	$1.8B-20.6%	$2.3B+128.5%	$1.0B-14.5%	$1.2B-29.3%	$1.7B+44.3%	$1.2B-5.1%	$1.2B+79.2%	$683.0M-35.0%	$1.1B-42.1%	$1.8B+275.4%	$483.0M-51.1%	$988.0M
Interest Expense	$723.0M	$701.0M+3.7%	$676.0M-6.1%	$720.0M+77.8%	$405.0M+345.1%	$91.0M-16.5%	$109.0M-5.2%	$115.0M-8.0%	$125.0M+2.5%	$122.0M+1.7%	$120.0M+0.8%	$119.0M-19.0%	$147.0M-14.5%	$172.0M-7.0%	$185.0M-16.3%	$221.0M
Income Tax	$22.0M	-$90.0M-117.8%	$507.0M+163.8%	-$795.0M-62.6%	-$489.0M-248.2%	$330.0M+33.6%	$247.0M+99.2%	$124.0M-57.5%	$292.0M+37.1%	$213.0M+74.6%	$122.0M-39.3%	$201.0M-36.0%	$314.0M-38.2%	$508.0M+1023.6%	-$55.0M-136.9%	$149.0M
Net Income	-$1.2B	-$1.2B+24.4%	-$1.5B-179.4%	$1.9B+2.6%	$1.9B+0.2%	$1.9B-4.8%	$2.0B+133.0%	$852.0M-29.4%	$1.2B+43.2%	$843.0M-6.3%	$900.0M+196.1%	$304.0M-51.3%	$624.0M-43.3%	$1.1B+196.0%	$372.0M-38.7%	$607.0M
EPS (Basic)	N/A	-$10.64+24.6%	-$14.11-179.0%	$17.85+2.1%	$17.48+2.9%	$16.99+0.8%	$16.85+144.9%	$6.88-23.5%	$8.99+47.1%	$6.11-1.6%	$6.21+207.4%	$2.02-49.9%	$4.03-41.8%	$6.93+194.9%	$2.35-39.6%	$3.89
EPS (Diluted)	-$10.69	-$10.64+24.6%	-$14.11-179.4%	$17.76+2.4%	$17.34+2.8%	$16.86+0.7%	$16.75+144.9%	$6.84-23.2%	$8.91+46.3%	$6.09-1.5%	$6.18+209.0%	$2.00-50.0%	$4.00-42.1%	$6.91+196.6%	$2.33-39.0%	$3.82
Diluted Shares (Avg)	N/A	110M+0.2%	109M-0.1%	109M+0.1%	109M-2.5%	112M-5.4%	118M-5.0%	125M-7.9%	135M-2.1%	138M-5.0%	146M-4.3%	152M-2.5%	156M-2.0%	159M-0.3%	160M+0.6%	159M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$2.8B+8.7%	$2.3B-2.2%	$2.2B-6.5%	$2.4B-8.6%	$2.5B-4.5%	$2.4B-8.5%	$2.4B-7.7%	$2.6B-2.8%
Cost of Revenue	$2.1B+6.8%	$1.9B-2.4%	$1.8B-3.0%	$1.9B-6.5%	$2.0B-0.6%	$1.9B-6.9%	$1.8B-6.4%	$2.0B-1.0%
Gross Profit	$618.0M+15.7%	$468.0M-1.3%	$423.0M-19.0%	$521.0M-15.8%	$534.0M-16.7%	$474.0M-14.4%	$522.0M-12.0%	$619.0M-8.0%
R&D Expenses	$29.0M-6.5%	$28.0M-9.7%	$32.0M+3.2%	$31.0M-3.1%	$31.0M-6.1%	$31.0M-8.8%	$31.0M-3.1%	$32.0M0.0%
SG&A Expenses	$251.0M+17.3%	$226.0M-2.2%	$223.0M-15.8%	$231.0M-6.9%	$214.0M-16.1%	$231.0M-12.8%	$265.0M-3.3%	$248.0M+1.6%
Operating Income	$276.0M+19.5%	$214.0M+29.7%	$93.0M+106.5%	-$1.3B-620.4%	$231.0M-7.6%	$165.0M-21.4%	-$1.4B-701.3%	$245.0M-70.9%
EBITDA	$520.0M+23.5%	$415.0M+20.3%	$289.0M+123.3%	-$1.1B-341.3%	$421.0M-4.8%	$345.0M-20.0%	-$1.2B-391.1%	$448.0M-55.9%
Interest Expense	$186.0M+5.1%	$183.0M+7.6%	$177.0M+7.9%	$177.0M+4.7%	$177.0M+1.7%	$170.0M+0.6%	$164.0M-7.9%	$169.0M-5.1%
Income Tax	$11.0M+114.3%	$33.0M+266.7%	-$15.0M-103.9%	-$7.0M-111.5%	-$77.0M-365.5%	$9.0M-72.7%	$384.0M+166.2%	$61.0M+125.8%
Net Income	$125.0M-36.5%	$44.0M+283.3%	$19.0M+101.0%	-$1.4B-1300.9%	$197.0M+27.1%	-$24.0M-119.8%	-$1.9B-383.6%	$113.0M-88.1%
EPS (Basic)	$1.14-36.7%	$0.40+281.8%	$0.17+101.0%	-$12.39-1302.9%	$1.80+26.8%	-$0.22-119.8%	-$17.52-373.3%	$1.03-88.2%
EPS (Diluted)	$1.13-37.2%	$0.40+281.8%	$0.17+101.0%	-$12.39-1302.9%	$1.80+27.7%	-$0.22-120.0%	-$17.51-374.5%	$1.03-88.1%
Diluted Shares (Avg)	110M+0.5%	110M+0.5%	N/A	110M0.0%	110M+0.2%	109M-0.1%	N/A	110M+0.1%

CE Balance Sheet

CE quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$21.7B-5.0%	$22.8B-14.1%	$26.6B+1.2%	$26.3B+119.4%	$12.0B+9.8%	$10.9B+15.1%	$9.5B+1.8%	$9.3B-2.4%	$9.5B+14.1%	$8.4B-2.7%	$8.6B-2.4%	$8.8B-2.5%	$9.0B+0.2%	$9.0B+5.7%	$8.5B
Current Assets	$5.7B+11.1%	$5.1B-17.6%	$6.2B-5.9%	$6.6B+73.7%	$3.8B+1.2%	$3.8B+36.1%	$2.8B-3.8%	$2.9B+2.9%	$2.8B+12.9%	$2.5B-11.3%	$2.8B+3.3%	$2.7B-15.2%	$3.2B+12.1%	$2.8B+5.0%	$2.7B
Cash & Equivalents	$1.3B+31.3%	$962.0M-46.7%	$1.8B+19.7%	$1.5B+181.3%	$536.0M-43.9%	$955.0M+106.3%	$463.0M+5.5%	$439.0M-23.8%	$576.0M-9.7%	$638.0M-34.0%	$967.0M+24.0%	$780.0M-20.7%	$984.0M+2.6%	$959.0M+40.6%	$682.0M
Short-Term Investments	$0	$0	$0	$0-100.0%	$10.0M-98.1%	$533.0M+1232.5%	$40.0M+29.0%	$31.0M-3.1%	$32.0M+6.7%	$30.0M0.0%	$30.0M-6.3%	$32.0M-22.0%	$41.0M-22.6%	$53.0M-17.2%	$64.0M
Inventory	$2.2B-2.8%	$2.3B-3.1%	$2.4B-16.1%	$2.8B+84.3%	$1.5B+55.8%	$978.0M-5.8%	$1.0B-0.8%	$1.0B+16.2%	$900.0M+25.0%	$720.0M+5.6%	$682.0M-12.8%	$782.0M-2.7%	$804.0M+13.1%	$711.0M-0.1%	$712.0M
Accounts Receivable	$922.0M-17.8%	$1.1B-9.8%	$1.2B-9.9%	$1.4B+18.8%	$1.2B+46.6%	$792.0M-6.8%	$850.0M-16.4%	$1.0B+3.1%	$986.0M+23.1%	$801.0M+13.5%	$706.0M-11.9%	$801.0M-7.6%	$867.0M+4.8%	$827.0M-5.1%	$871.0M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.2B-22.6%	$5.4B-22.8%	$7.0B-2.3%	$7.1B+405.8%	$1.4B+21.1%	$1.2B+8.6%	$1.1B+1.6%	$1.1B+5.4%	$1.0B+26.0%	$796.0M+12.9%	$705.0M-5.9%	$749.0M-6.1%	$798.0M+2.7%	$777.0M+2.2%	$760.0M
Total Liabilities	$17.6B-0.4%	$17.7B-9.3%	$19.5B-5.3%	$20.6B+165.0%	$7.8B+5.5%	$7.4B+5.9%	$7.0B+10.1%	$6.3B-4.8%	$6.7B+15.3%	$5.8B-7.1%	$6.2B+3.8%	$6.0B-5.4%	$6.3B-13.1%	$7.3B+1.3%	$7.2B
Current Liabilities	$3.7B-5.3%	$3.9B-4.5%	$4.1B+0.1%	$4.1B+62.4%	$2.5B+27.0%	$2.0B+12.5%	$1.8B-1.4%	$1.8B+14.1%	$1.6B+44.8%	$1.1B-30.5%	$1.6B+15.8%	$1.3B-13.4%	$1.5B+14.0%	$1.4B-2.2%	$1.4B
Non-Current Liabilities	$14.0B+1.0%	$13.8B-10.6%	$15.5B-6.7%	$16.6B+213.7%	$5.3B-2.4%	$5.4B+12.1%	$4.8B+16.1%	$4.2B-11.2%	$4.7B+9.9%	$4.3B+1.2%	$4.2B-3.9%	$4.4B-8.3%	$4.8B-19.3%	$5.9B+2.1%	$5.8B
Long-Term Debt	$11.4B+2.9%	$11.1B-9.9%	$12.3B-8.0%	$13.4B+321.1%	$3.2B-1.6%	$3.2B-5.3%	$3.4B+14.8%	$3.0B-10.4%	$3.3B+14.7%	$2.9B+17.1%	$2.5B-4.6%	$2.6B-10.4%	$2.9B-1.5%	$2.9B+2.0%	$2.9B
Total Equity	$4.0B-21.1%	$5.1B-27.4%	$7.1B+25.3%	$5.6B+34.6%	$4.2B+18.8%	$3.5B+40.6%	$2.5B-16.0%	$3.0B+3.4%	$2.9B+11.6%	$2.6B+8.8%	$2.4B-15.6%	$2.8B+4.4%	$2.7B+56.0%	$1.7B+29.0%	$1.3B
Retained Earnings	$9.9B-10.7%	$11.1B-14.5%	$12.9B+14.7%	$11.3B+16.5%	$9.7B+19.6%	$8.1B+26.4%	$6.4B+9.4%	$5.8B+18.8%	$4.9B+13.9%	$4.3B+19.3%	$3.6B+3.7%	$3.5B+15.9%	$3.0B+51.1%	$2.0B+19.8%	$1.7B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$21.4B-9.7%	$21.7B-6.3%	$21.7B-5.0%	$22.2B-14.4%	$23.7B-8.1%	$23.2B-10.9%	$22.8B-14.1%	$25.9B+1.4%
Current Assets	$5.8B+2.1%	$6.0B+10.2%	$5.7B+11.1%	$6.1B+6.7%	$5.7B-3.9%	$5.4B-8.9%	$5.1B-17.6%	$5.7B-3.1%
Cash & Equivalents	$1.4B+16.3%	$1.8B+84.9%	$1.3B+31.3%	$1.4B+77.1%	$1.2B-1.0%	$951.0M-35.9%	$962.0M-46.7%	$813.0M-40.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$2.3B+0.7%	$2.3B-1.1%	$2.2B-2.8%	$2.2B-13.6%	$2.3B-7.1%	$2.3B-1.9%	$2.3B-3.1%	$2.6B+9.6%
Accounts Receivable	$1.3B+5.9%	$1.1B-11.5%	$922.0M-17.8%	$1.0B-24.1%	$1.2B-3.8%	$1.2B-3.8%	$1.1B-9.8%	$1.4B+2.1%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.2B-24.1%	$4.2B-23.2%	$4.2B-22.6%	$4.2B-40.4%	$5.5B-20.8%	$5.4B-21.8%	$5.4B-22.8%	$7.0B+0.1%
Total Liabilities	$17.2B-6.6%	$17.7B-2.1%	$17.6B-0.4%	$18.2B-2.3%	$18.5B-1.1%	$18.1B-4.8%	$17.7B-9.3%	$18.7B-2.1%
Current Liabilities	$4.0B+44.8%	$4.3B+54.3%	$3.7B-5.3%	$3.7B-10.4%	$2.8B-40.2%	$2.8B-43.2%	$3.9B-4.5%	$4.2B+15.0%
Non-Current Liabilities	$13.2B-15.7%	$13.4B-12.5%	$14.0B+1.0%	$14.5B0.0%	$15.7B+11.8%	$15.3B+8.7%	$13.8B-10.6%	$14.5B-6.1%
Long-Term Debt	$10.7B-15.7%	$10.8B-12.6%	$11.4B+2.9%	$11.7B+2.9%	$12.7B+14.7%	$12.4B+12.3%	$11.1B-9.9%	$11.3B-7.9%
Total Equity	$4.2B-20.7%	$4.1B-20.9%	$4.0B-21.1%	$4.0B-45.4%	$5.3B-26.5%	$5.1B-27.4%	$5.1B-27.4%	$7.2B+11.5%
Retained Earnings	$10.0B-10.7%	$9.9B-10.5%	$9.9B-10.7%	$9.9B-24.7%	$11.2B-13.9%	$11.1B-14.6%	$11.1B-14.5%	$13.1B+6.4%

CE Cash Flow Statement

CE quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$984.0M	$1.1B+18.6%	$966.0M-49.1%	$1.9B+4.4%	$1.8B+3.5%	$1.8B+30.8%	$1.3B-7.6%	$1.5B-6.7%	$1.6B+94.0%	$803.0M-10.1%	$893.0M+3.6%	$862.0M-10.4%	$962.0M+26.2%	$762.0M+5.5%	$722.0M+13.2%	$638.0M
Depreciation & Amortization	N/A	$760.0M-5.1%	$801.0M+13.5%	$706.0M+52.8%	$462.0M+24.5%	$371.0M+6.0%	$350.0M-0.6%	$352.0M+2.6%	$343.0M+12.5%	$305.0M+5.2%	$290.0M-18.8%	$357.0M+22.3%	$292.0M-4.3%	$305.0M-1.0%	$308.0M+3.4%	$298.0M
Stock-Based Compensation	N/A	$24.0M-25.0%	$32.0M-20.0%	$40.0M-33.3%	$60.0M-36.8%	$95.0M+239.3%	$28.0M-41.7%	$48.0M-32.4%	$71.0M+51.1%	$47.0M+51.6%	$31.0M-22.5%	$40.0M-13.0%	$46.0M+91.7%	$24.0M+20.0%	$20.0M	N/A
Capital Expenditures	$276.0M	$343.0M-21.1%	$435.0M-23.4%	$568.0M+4.6%	$543.0M+16.3%	$467.0M+28.3%	$364.0M-1.6%	$370.0M+9.8%	$337.0M+26.2%	$267.0M+8.5%	$246.0M+6.0%	$232.0M-8.7%	$254.0M-8.3%	$277.0M-20.6%	$349.0M0.0%	$349.0M
Free Cash Flow	$708.0M	$803.0M+51.2%	$531.0M-60.1%	$1.3B+4.3%	$1.3B-1.1%	$1.3B+31.8%	$979.0M-9.7%	$1.1B-11.2%	$1.2B+127.8%	$536.0M-17.2%	$647.0M+2.7%	$630.0M-11.0%	$708.0M+46.0%	$485.0M+30.0%	$373.0M+29.1%	$289.0M
Investing Cash Flow	$203.0M	-$349.0M+25.7%	-$470.0M-250.7%	-$134.0M+98.8%	-$11.1B-895.6%	-$1.1B-289.0%	$592.0M+220.1%	-$493.0M+2.8%	-$507.0M+7.7%	-$549.0M-25.1%	-$439.0M+21.3%	-$558.0M+20.9%	-$705.0M-67.1%	-$422.0M+15.6%	-$500.0M-13.4%	-$441.0M
Financing Cash Flow	-$991.0M	-$513.0M+60.9%	-$1.3B+9.8%	-$1.5B-114.1%	$10.3B+1087.5%	-$1.0B+29.2%	-$1.5B-57.3%	-$935.0M+19.7%	-$1.2B-231.9%	-$351.0M+53.8%	-$759.0M-1050.0%	-$66.0M+84.1%	-$415.0M-27.3%	-$326.0M-765.3%	$49.0M+119.4%	-$253.0M
Dividends Paid	$13.0M	$13.0M-95.8%	$307.0M+0.7%	$305.0M+2.7%	$297.0M-2.3%	$304.0M+3.8%	$293.0M-2.3%	$300.0M+7.1%	$280.0M+16.2%	$241.0M+19.9%	$201.0M+15.5%	$174.0M+20.8%	$144.0M+73.5%	$83.0M+93.0%	$43.0M+26.5%	$34.0M
Share Buybacks	N/A	N/A	$0	$0-100.0%	$17.0M-98.3%	$1.0B+53.8%	$650.0M-34.7%	$996.0M+23.7%	$805.0M+61.0%	$500.0M0.0%	$500.0M+19.0%	$420.0M+68.0%	$250.0M+52.4%	$164.0M+264.4%	$45.0M+45.2%	$31.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$209.0M-49.0%	$76.0M+105.4%	$252.0M-49.0%	$447.0M+465.8%	$410.0M+40.4%	$37.0M-63.4%	$494.0M-40.5%	$79.0M-80.4%
Depreciation & Amortization	$244.0M+28.4%	$201.0M+11.7%	$196.0M+5.9%	$194.0M-4.4%	$190.0M-1.0%	$180.0M-18.6%	$185.0M-2.1%	$203.0M+17.3%
Stock-Based Compensation	N/A	$8.0M+60.0%	N/A	N/A	N/A	$5.0M-50.0%	N/A	N/A
Capital Expenditures	$62.0M-33.3%	$66.0M-35.3%	$84.0M-20.0%	$64.0M-27.3%	$93.0M-11.4%	$102.0M-25.5%	$105.0M-18.0%	$88.0M-32.8%
Free Cash Flow	$147.0M-53.6%	$10.0M+115.4%	$168.0M-56.8%	$383.0M+4355.6%	$317.0M+69.5%	-$65.0M-80.6%	$389.0M-44.6%	-$9.0M-103.3%
Investing Cash Flow	-$59.0M+33.0%	$425.0M+533.7%	-$104.0M+18.8%	-$59.0M+41.0%	-$88.0M+3.3%	-$98.0M+35.1%	-$128.0M+23.8%	-$100.0M-126.7%
Financing Cash Flow	-$546.0M-370.7%	-$3.0M-106.7%	-$324.0M-71.4%	-$118.0M+68.6%	-$116.0M+76.3%	$45.0M+117.4%	-$189.0M+21.3%	-$376.0M+46.3%
Dividends Paid	$3.0M0.0%	$3.0M0.0%	$4.0M-94.8%	$3.0M-96.1%	$3.0M-96.1%	$3.0M-96.1%	$77.0M0.0%	$76.0M0.0%

Not reported in any period shown, so not listed: Share Buybacks.

CE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CE quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	20.4%-2.3pp	22.8%-0.9pp	23.6%-1.0pp	24.6%-6.8pp	31.4%+8.6pp	22.9%-2.6pp	25.5%-2.1pp	27.6%+2.9pp	24.6%-1.5pp	26.1%+2.8pp	23.2%-0.5pp	23.8%+2.8pp	21.0%+2.6pp	18.4%-2.8pp	21.2%
Operating Margin	-8.2%-1.2pp	-7.0%-22.3pp	15.2%+1.0pp	14.2%-8.5pp	22.8%+11.0pp	11.7%-1.5pp	13.2%-5.4pp	18.6%+4.7pp	14.0%-3.4pp	17.3%+11.6pp	5.8%-5.4pp	11.1%-12.0pp	23.2%+20.4pp	2.7%-7.5pp	10.2%
Net Margin	-12.2%+2.8pp	-15.0%-32.8pp	17.8%-1.8pp	19.6%-2.6pp	22.1%-13.0pp	35.1%+21.6pp	13.5%-3.3pp	16.9%+3.1pp	13.7%-3.0pp	16.7%+11.3pp	5.4%-3.8pp	9.2%-7.7pp	16.9%+11.1pp	5.8%-3.2pp	9.0%
Return on Equity	-28.8%+1.3pp	-30.1%-57.6pp	27.5%-6.1pp	33.6%-11.5pp	45.1%-11.2pp	56.3%+22.3pp	34.0%-6.5pp	40.5%+11.3pp	29.2%-5.6pp	34.8%+22.0pp	12.8%-9.4pp	22.1%-18.6pp	40.8%+19.3pp	21.5%-23.8pp	45.3%
Return on Assets	-5.4%+1.4pp	-6.8%-14.1pp	7.3%+0.1pp	7.2%-8.6pp	15.8%-2.4pp	18.2%+9.2pp	9.0%-4.0pp	13.0%+4.1pp	8.8%-1.9pp	10.8%+7.2pp	3.5%-3.6pp	7.1%-5.1pp	12.2%+8.1pp	4.1%-3.0pp	7.1%
Current Ratio	1.55+0.2x	1.32-0.2x	1.53-0.1x	1.63+0.1x	1.52-0.4x	1.91+0.3x	1.580.0x	1.62-0.2x	1.79-0.5x	2.30+0.5x	1.80-0.2x	2.020.0x	2.060.0x	2.10+0.1x	1.95
Debt-to-Equity	2.81+0.7x	2.16+0.4x	1.74-0.6x	2.37+1.6x	0.76-0.2x	0.92-0.4x	1.36+0.4x	1.00-0.2x	1.150.0x	1.12+0.1x	1.04+0.1x	0.92-0.2x	1.07-0.6x	1.69-0.4x	2.14
Asset Turnover	0.440.0x	0.450.0x	0.410.0x	0.37-0.3x	0.71+0.2x	0.52-0.1x	0.66-0.1x	0.77+0.1x	0.640.0x	0.640.0x	0.66-0.1x	0.77+0.1x	0.720.0x	0.71-0.1x	0.79
FCF Margin	8.4%+3.2pp	5.2%-7.0pp	12.2%-1.0pp	13.2%-1.9pp	15.1%-2.2pp	17.3%+0.1pp	17.2%+0.2pp	17.1%+8.3pp	8.7%-3.3pp	12.0%+0.9pp	11.1%+0.7pp	10.4%+3.0pp	7.4%+1.6pp	5.8%+1.5pp	4.3%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	22.5%+1.4pp	20.0%+0.2pp	19.2%-3.0pp	21.5%-1.8pp	21.1%-3.1pp	19.8%-1.4pp	22.1%-1.1pp	23.4%-1.3pp
Operating Margin	10.0%+0.9pp	9.2%+2.3pp	4.2%+64.6pp	-52.7%-62.0pp	9.1%-0.3pp	6.9%-1.1pp	-60.4%-69.7pp	9.3%-21.7pp
Net Margin	4.5%-3.2pp	1.9%+2.9pp	0.9%+82.8pp	-56.1%-60.4pp	7.8%+1.9pp	-1.0%-5.6pp	-81.9%-108.5pp	4.3%-30.6pp
Return on Equity	3.0%-0.8pp	1.1%+1.6pp	0.5%+38.1pp	-34.3%-35.9pp	3.8%+1.6pp	-0.5%-2.2pp	-37.6%-47.3pp	1.6%-13.1pp
Return on Assets	0.6%-0.3pp	0.2%+0.3pp	0.1%+8.5pp	-6.1%-6.6pp	0.8%+0.2pp	-0.1%-0.6pp	-8.5%-11.0pp	0.4%-3.3pp
Current Ratio	1.45-0.6x	1.38-0.6x	1.55+0.2x	1.63+0.3x	2.05+0.8x	1.94+0.7x	1.32-0.2x	1.37-0.3x
Debt-to-Equity	2.57+0.2x	2.66+0.3x	2.81+0.7x	2.95+1.4x	2.42+0.9x	2.41+0.9x	2.16+0.4x	1.56-0.3x
Asset Turnover	0.130.0x	0.110.0x	0.100.0x	0.110.0x	0.110.0x	0.100.0x	0.100.0x	0.100.0x
FCF Margin	5.3%-7.2pp	0.4%+3.1pp	7.6%-8.9pp	15.8%+16.2pp	12.5%+5.5pp	-2.7%-1.3pp	16.5%-11.0pp	-0.3%-10.3pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Celanese Corporation CE	FY2025	$9.5B	-$1.2B	-12.2%	$4.8B	32/100
Olin Corp. OLN	FY2025	$6.8B	-$101.1M	-1.5%	$1.8B	34/100
Methanex Corp MEOH	FY2025	$3.6B	$144.8M	4.0%	$4.7B	41/100
Huntsman Corporation HUN	FY2025	$5.7B	-$284.0M	-5.0%	$1.5B	25/100
Dow Inc. DOW	FY2025	$40.0B	-$2.4B	-6.1%	$20.3B	24/100

Where Celanese Corporation Ranks

Frequently Asked Questions

What is Celanese Corporation's annual revenue?

Celanese Corporation (CE) reported $9.5B in total revenue for fiscal year 2025. This represents a -7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Celanese Corporation's revenue growing?

Celanese Corporation (CE) revenue declined by 7.1% year-over-year, from $10.3B to $9.5B in fiscal year 2025.

Is Celanese Corporation profitable?

No, Celanese Corporation (CE) reported a net income of -$1.2B in fiscal year 2025, with a net profit margin of -12.2%.

What is Celanese Corporation's EBITDA?

Celanese Corporation (CE) had EBITDA of -$26.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Celanese Corporation have?

As of fiscal year 2025, Celanese Corporation (CE) had $1.3B in cash and equivalents against $11.4B in long-term debt.

What is Celanese Corporation's gross margin?

Celanese Corporation (CE) had a gross margin of 20.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Celanese Corporation's operating margin?

Celanese Corporation (CE) had an operating margin of -8.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Celanese Corporation's net profit margin?

Celanese Corporation (CE) had a net profit margin of -12.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Celanese Corporation's return on equity (ROE)?

Celanese Corporation (CE) has a return on equity of -28.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Celanese Corporation's free cash flow?

Celanese Corporation (CE) generated $803.0M in free cash flow during fiscal year 2025. This represents a 51.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Celanese Corporation's operating cash flow?

Celanese Corporation (CE) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Celanese Corporation's total assets?

Celanese Corporation (CE) had $21.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Celanese Corporation's capital expenditures?

Celanese Corporation (CE) invested $343.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Celanese Corporation spend on research and development?

Celanese Corporation (CE) invested $125.0M in research and development during fiscal year 2025.

How many shares does Celanese Corporation have outstanding?

Celanese Corporation (CE) had 110M shares outstanding as of fiscal year 2025.

What is Celanese Corporation's current ratio?

Celanese Corporation (CE) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.

What is Celanese Corporation's debt-to-equity ratio?

Celanese Corporation (CE) had a debt-to-equity ratio of 2.81 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Celanese Corporation's return on assets (ROA)?

Celanese Corporation (CE) had a return on assets of -5.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Celanese Corporation's P/E ratio?

Celanese Corporation (CE) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $4.8B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Celanese Corporation's price-to-sales ratio?

Celanese Corporation (CE) trades at 0.5x sales, its market capitalization divided by revenue of $9.7B revenue, trailing 12 months to June 30, 2026. The market capitalization is $4.8B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Celanese Corporation's Altman Z-Score?

Celanese Corporation (CE) has an Altman Z-Score of 1.23, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Celanese Corporation's Piotroski F-Score?

Celanese Corporation (CE) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Celanese Corporation's earnings high quality?

Celanese Corporation (CE) reported a net loss of $1.2B while generating $1.1B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Celanese Corporation cover its interest payments?

Celanese Corporation (CE) reported an operating loss of $786.0M against $701.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Celanese Corporation?

Celanese Corporation (CE) scores 32 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.